Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Peripheral Arterial Disease D058729 7 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Farber Lipogranulomatosis D055577 1 associated lipids
Acute Lung Injury D055371 33 associated lipids
Lung Injury D055370 14 associated lipids
Niemann-Pick Disease, Type C D052556 1 associated lipids
Atherosclerosis D050197 85 associated lipids
Ileus D045823 3 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Endotoxemia D019446 27 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Teratocarcinoma D018243 7 associated lipids
Weight Gain D015430 101 associated lipids
Reperfusion Injury D015427 65 associated lipids
Vascular Diseases D014652 16 associated lipids
Tuberculosis D014376 20 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Thrombocytopenia D013921 15 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Sensation Disorders D012678 2 associated lipids
Sarcoma 180 D012510 21 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Retinal Detachment D012163 10 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pulmonary Edema D011654 23 associated lipids
Psoriasis D011565 47 associated lipids
Proteinuria D011507 30 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Pregnancy, Ectopic D011271 5 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Pain D010146 64 associated lipids
Ovarian Diseases D010049 5 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Neuroblastoma D009447 66 associated lipids
Neuralgia D009437 28 associated lipids
Nerve Degeneration D009410 53 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Cardiomyopathies D009202 10 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Melanoma D008545 69 associated lipids
Lung Neoplasms D008175 171 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Leukemia D007938 74 associated lipids
Insulinoma D007340 28 associated lipids
Insulin Resistance D007333 99 associated lipids
Influenza, Human D007251 11 associated lipids
Inflammation D007249 119 associated lipids
Hypertension D006973 115 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Hypersensitivity D006967 22 associated lipids
Hyperalgesia D006930 42 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hemolysis D006461 131 associated lipids
Heart Failure D006333 36 associated lipids
Glioma D005910 112 associated lipids
Glioblastoma D005909 27 associated lipids
Fibrosis D005355 23 associated lipids
Eye Abnormalities D005124 7 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Edema D004487 152 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Coronary Disease D003327 70 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colitis D003092 69 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Asthma D001249 52 associated lipids
Arthritis D001168 41 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Fabry Disease D000795 4 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Anemia D000740 21 associated lipids
Anaphylaxis D000707 35 associated lipids
Adenoma D000236 40 associated lipids
Adenocarcinoma D000230 166 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Florio T et al. Basic fibroblast growth factor activates endothelial nitric-oxide synthase in CHO-K1 cells via the activation of ceramide synthesis. 2003 Mol. Pharmacol. pmid:12527801
Cho H et al. The aorta and heart differentially express RGS (regulators of G-protein signalling) proteins that selectively regulate sphingosine 1-phosphate, angiotensin II and endothelin-1 signalling. 2003 Biochem. J. pmid:12564955
Jin Y et al. Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation. 2003 Blood pmid:12586615
Dziak R et al. Effects of sphingosine-1-phosphate and lysophosphatidic acid on human osteoblastic cells. 2003 Prostaglandins Leukot. Essent. Fatty Acids pmid:12591009
Perry DK and Kolesnick RN Ceramide and sphingosine 1-phosphate in anti-cancer therapies. 2003 Cancer Treat. Res. pmid:12613204
Deroanne C et al. EphrinA1 inactivates integrin-mediated vascular smooth muscle cell spreading via the Rac/PAK pathway. 2003 J. Cell. Sci. pmid:12615978
Fueller M et al. Activation of human monocytic cells by lysophosphatidic acid and sphingosine-1-phosphate. 2003 Cell. Signal. pmid:12618211
Niedernberg A et al. Sphingosine 1-phosphate and dioleoylphosphatidic acid are low affinity agonists for the orphan receptor GPR63. 2003 Cell. Signal. pmid:12618218
Honig SM et al. FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes. 2003 J. Clin. Invest. pmid:12618517
Meyer zu Heringdorf D et al. Photolysis of intracellular caged sphingosine-1-phosphate causes Ca2+ mobilization independently of G-protein-coupled receptors. 2003 FEBS Lett. pmid:14623109
Dolezalova H et al. Biochemical regulation of breast cancer cell expression of S1P2 (Edg-5) and S1P3 (Edg-3) G protein-coupled receptors for sphingosine 1-phosphate. 2003 J. Cell. Biochem. pmid:12577307
Rosenfeldt HM et al. Sphingosine-1-phosphate stimulates contraction of human airway smooth muscle cells. 2003 FASEB J. pmid:14519658
Meacci E et al. Activation of phospholipase D by bradykinin and sphingosine 1-phosphate in A549 human lung adenocarcinoma cells via different GTP-binding proteins and protein kinase C delta signaling pathways. 2003 Biochemistry pmid:12525155
Katsuma S et al. Transcriptional profiling of gene expression patterns during sphingosine 1-phosphate-induced mesangial cell proliferation. 2003 Biochem. Biophys. Res. Commun. pmid:12504122
Kim DS et al. Sphingosine-1-phosphate promotes mouse melanocyte survival via ERK and Akt activation. 2003 Cell. Signal. pmid:12873705
Kohno T et al. Sphingosine 1-phosphate promotes cell migration through the activation of Cdc42 in Edg-6/S1P4-expressing cells. 2003 Genes Cells pmid:12875654
Worrall D et al. Sphingolipids, new players in plant signaling. 2003 Trends Plant Sci. pmid:12878015
Deutschman DH et al. Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate. 2003 Am. Heart J. pmid:12851609
Burnett C and Howard K Fly and mammalian lipid phosphate phosphatase isoforms differ in activity both in vitro and in vivo. 2003 EMBO Rep. pmid:12856002
Laychock SG et al. Endothelial differentiation gene receptors in pancreatic islets and INS-1 cells. 2003 Diabetes pmid:12882914
Sauer B et al. Antiapoptotic action of 1alpha,25-dihydroxyvitamin D3 in primary human melanocytes. 2003 Melanoma Res. pmid:12883359
Pettus BJ et al. The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha. 2003 FASEB J. pmid:12890694
Gratzinger D et al. Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho. 2003 FASEB J. pmid:12890700
Muraki K and Imaizumi Y A novel action of palmitoyl-L-carnitine in human vascular endothelial cells. 2003 J. Pharmacol. Sci. pmid:12890891
Kihara A et al. Sphingosine-1-phosphate lyase is involved in the differentiation of F9 embryonal carcinoma cells to primitive endoderm. 2003 J. Biol. Chem. pmid:12584204
Berg C et al. Platelets induce reactive oxygen species-dependent growth of human skin fibroblasts. 2003 Eur. J. Cell Biol. pmid:14703013
Bencini C et al. Effects of sphingosine 1-phosphate on excitation-contraction coupling in mammalian skeletal muscle. 2003 J. Muscle Res. Cell. Motil. pmid:14870969
Brailoiu E et al. Modulation of spontaneous transmitter release from the frog neuromuscular junction by interacting intracellular Ca(2+) stores: critical role for nicotinic acid-adenine dinucleotide phosphate (NAADP). 2003 Biochem. J. pmid:12749764
Hla T Signaling and biological actions of sphingosine 1-phosphate. 2003 Pharmacol. Res. pmid:12676514
Buccoliero R and Futerman AH The roles of ceramide and complex sphingolipids in neuronal cell function. 2003 Pharmacol. Res. pmid:12676515
Bernatchez PN et al. Sphingosine 1-phosphate effect on endothelial cell PAF synthesis: role in cellular migration. 2003 J. Cell. Biochem. pmid:14587028
Meacci E et al. Down-regulation of EDG5/S1P2 during myogenic differentiation results in the specific uncoupling of sphingosine 1-phosphate signalling to phospholipase D. 2003 Biochim. Biophys. Acta pmid:14499732
Clair T et al. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. 2003 Cancer Res. pmid:14500380
Dorsam G et al. Transduction of multiple effects of sphingosine 1-phosphate (S1P) on T cell functions by the S1P1 G protein-coupled receptor. 2003 J. Immunol. pmid:14500646
Facchinetti MM et al. Differential branching of the sphingolipid metabolic pathways with the stage of development. Involvement of sphingosine kinase. 2003 Biol. Neonate pmid:14504448
Clemens JJ et al. Synthesis of para-alkyl aryl amide analogues of sphingosine-1-phosphate: discovery of potent S1P receptor agonists. 2003 Bioorg. Med. Chem. Lett. pmid:14505636
Shikata Y et al. Involvement of site-specific FAK phosphorylation in sphingosine-1 phosphate- and thrombin-induced focal adhesion remodeling: role of Src and GIT. 2003 FASEB J. pmid:14656986
Banno Y et al. Involvement of phospholipase D in insulin-like growth factor-I-induced activation of extracellular signal-regulated kinase, but not phosphoinositide 3-kinase or Akt, in Chinese hamster ovary cells. 2003 Biochem. J. pmid:12385647
Bolz SS et al. Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway. 2003 Circulation pmid:12796138
Kim JI et al. Sphingosine 1-phosphate in amniotic fluid modulates cyclooxygenase-2 expression in human amnion-derived WISH cells. 2003 J. Biol. Chem. pmid:12796504
Thors B et al. Inhibition of Akt phosphorylation by thrombin, histamine and lysophosphatidylcholine in endothelial cells. Differential role of protein kinase C. 2003 Atherosclerosis pmid:12801607
Yamaguchi H et al. Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells. 2003 Biochem. J. pmid:12803545
Miura S et al. Ras/Raf1-dependent signal in sphingosine-1-phosphate-induced tube formation in human coronary artery endothelial cells. 2003 Biochem. Biophys. Res. Commun. pmid:12821130
Vogler R et al. Sphingosine-1-phosphate and its potentially paradoxical effects on critical parameters of cutaneous wound healing. 2003 J. Invest. Dermatol. pmid:12648236
Bollag WB Paradoxical effects of sphingosine-1-phosphate. 2003 J. Invest. Dermatol. pmid:12648243
Uhlenbrock K et al. Fluid shear stress differentially regulates gpr3, gpr6, and gpr12 expression in human umbilical vein endothelial cells. 2003 Cell. Physiol. Biochem. pmid:12649592
Gómez-Muñoz A et al. Sphingosine-1-phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages. 2003 FEBS Lett. pmid:12650926
Kimura T et al. High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. 2003 Arterioscler. Thromb. Vasc. Biol. pmid:12775579
Duan HF et al. [Progress in the study of physiological function of sphingosine 1-phosphate]. 2003 Sheng Li Ke Xue Jin Zhan pmid:12778803
Salomone S et al. S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate. 2003 Eur. J. Pharmacol. pmid:12782194
Graeler MH et al. Protein kinase C epsilon dependence of the recovery from down-regulation of S1P1 G protein-coupled receptors of T lymphocytes. 2003 J. Biol. Chem. pmid:12782628
Van Brocklyn JR et al. Sphingosine-1-phosphate stimulates motility and invasiveness of human glioblastoma multiforme cells. 2003 Cancer Lett. pmid:12963123
Olivera A et al. Sphingosine kinase type 1 induces G12/13-mediated stress fiber formation, yet promotes growth and survival independent of G protein-coupled receptors. 2003 J. Biol. Chem. pmid:12963721
Bolz SS and Pohl U Highly effective non-viral gene transfer into vascular smooth muscle cells of cultured resistance arteries demonstrated by genetic inhibition of sphingosine-1-phosphate-induced vasoconstriction. 2003 Jul-Aug J. Vasc. Res. pmid:12913332
Meacci E et al. Sphingosine kinase activity is required for sphingosine-mediated phospholipase D activation in C2C12 myoblasts. 2004 Biochem. J. pmid:15109308
Lim HS et al. Syntheses of sphingosine-1-phosphate analogues and their interaction with EDG/S1P receptors. 2004 Bioorg. Med. Chem. Lett. pmid:15109640
Cui J et al. Role of ceramide in ischemic preconditioning. 2004 J. Am. Coll. Surg. pmid:15110811
Jolly PS et al. Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis. 2004 J. Exp. Med. pmid:15067032
Segura BJ et al. Sphingosine-1-phosphate mediates calcium signaling in guinea pig enteroglial cells. 2004 J. Surg. Res. pmid:14732348
Sanna MG et al. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. 2004 J. Biol. Chem. pmid:14732717
Forrest M et al. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes. 2004 J. Pharmacol. Exp. Ther. pmid:14747617
Yue J et al. Mice with transgenic overexpression of lipid phosphate phosphatase-1 display multiple organotypic deficits without alteration in circulating lysophosphatidate level. 2004 Cell. Signal. pmid:14687668
Harada J et al. Sphingosine-1-phosphate induces proliferation and morphological changes of neural progenitor cells. 2004 J. Neurochem. pmid:14756825
Matloubian M et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. 2004 Nature pmid:14737169
Monick MM et al. Sphingosine kinase mediates activation of extracellular signal-related kinase and Akt by respiratory syncytial virus. 2004 Am. J. Respir. Cell Mol. Biol. pmid:14742298
Panetti TS et al. Extracellular matrix molecules regulate endothelial cell migration stimulated by lysophosphatidic acid. 2004 J. Thromb. Haemost. pmid:15333043
Kohno T and Igarashi Y Roles for N-glycosylation in the dynamics of Edg-1/S1P1 in sphingosine 1-phosphate-stimulated cells. 2004 Glycoconj. J. pmid:15750791
Linz-McGillem LA et al. Cytoskeletal rearrangement and caspase activation in sphingosine 1-phosphate-induced lung capillary tube formation. 2004 Stem Cells Dev. pmid:15588507
Hammer S et al. Glucocorticoids mediate differential anti-apoptotic effects in human fibroblasts and keratinocytes via sphingosine-1-phosphate formation. 2004 J. Cell. Biochem. pmid:14991774
Tokuda H et al. Interleukin (IL)-17 enhances tumor necrosis factor-alpha-stimulated IL-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts. 2004 J. Cell. Biochem. pmid:15034939
Goetzl EJ and Gräler MH Sphingosine 1-phosphate and its type 1 G protein-coupled receptor: trophic support and functional regulation of T lymphocytes. 2004 J. Leukoc. Biol. pmid:14982946
Fukuda Y et al. Identification of PECAM-1 association with sphingosine kinase 1 and its regulation by agonist-induced phosphorylation. 2004 Biochim. Biophys. Acta pmid:14984734
Tanimoto T et al. Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells. 2004 Circ. Res. pmid:15044318
Sun C and Bittman R An efficient preparation of isosteric phosphonate analogues of sphingolipids by opening of oxirane and cyclic sulfamidate intermediates with alpha-lithiated alkylphosphonic esters. 2004 J. Org. Chem. pmid:15497998
Wang FX et al. mitochondrial ceramidase overexpression up-regulates Bcl-2 protein level in K562 cells, probably through its metabolite sphingosine-1-phosphate. 2004 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:15498114
Nakamura H et al. Effects of synthetic sphingosine-1-phosphate analogs on arachidonic acid metabolism and cell death. 2004 Biochem. Pharmacol. pmid:15498509
Billich A and Ettmayer P Fluorescence-based assay of sphingosine kinases. 2004 Anal. Biochem. pmid:14769343
Liu S et al. Glycogen synthase kinase 3beta is a negative regulator of growth factor-induced activation of the c-Jun N-terminal kinase. 2004 J. Biol. Chem. pmid:15466414
Birukov KG et al. Epoxycyclopentenone-containing oxidized phospholipids restore endothelial barrier function via Cdc42 and Rac. 2004 Circ. Res. pmid:15472119
Amano S et al. Increase of laminin 5 synthesis in human keratinocytes by acute wound fluid, inflammatory cytokines and growth factors, and lysophospholipids. 2004 Br. J. Dermatol. pmid:15541073
Nosi D et al. Effects of S1P on myoblastic cell contraction: possible involvement of Ca-independent mechanisms. 2004 Cells Tissues Organs (Print) pmid:15655330
Xin C et al. Heterologous desensitization of the sphingosine-1-phosphate receptors by purinoceptor activation in renal mesangial cells. 2004 Br. J. Pharmacol. pmid:15466446
Elices MJ Editorial overview: Tie me up, tie me down: immunosuppressive therapies for the 21st century. 2004 Curr Opin Investig Drugs pmid:15573862
Otala M et al. Protection from radiation-induced male germ cell loss by sphingosine-1-phosphate. 2004 Biol. Reprod. pmid:14613902
Kelley GG et al. Hormonal regulation of phospholipase Cepsilon through distinct and overlapping pathways involving G12 and Ras family G-proteins. 2004 Biochem. J. pmid:14567755
Yu N et al. Characterization of lysophosphatidic acid and sphingosine-1-phosphate-mediated signal transduction in rat cortical oligodendrocytes. 2004 Glia pmid:14648542
Matsushita K et al. Sphingosine 1-phosphate activates Weibel-Palade body exocytosis. 2004 Proc. Natl. Acad. Sci. U.S.A. pmid:15273282
Augé N et al. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. 2004 Circulation pmid:15277330
Chavakis T et al. Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis. 2004 FASEB J. pmid:15208269
Xu CB et al. Sphingosine signaling and atherogenesis. 2004 Acta Pharmacol. Sin. pmid:15210056
Yokoo E et al. Sphingosine 1-phosphate inhibits migration of RBL-2H3 cells via S1P2: cross-talk between platelets and mast cells. 2004 J. Biochem. pmid:15213242
Pierre SC et al. PAM mediates sustained inhibition of cAMP signaling by sphingosine-1-phosphate. 2004 EMBO J. pmid:15257286
McVerry BJ and Garcia JG Endothelial cell barrier regulation by sphingosine 1-phosphate. 2004 J. Cell. Biochem. pmid:15258893
Karliner JS Mechanisms of cardioprotection by lysophospholipids. 2004 J. Cell. Biochem. pmid:15258895
Goetzl EJ et al. Sphingosine 1-phosphate and its G protein-coupled receptors constitute a multifunctional immunoregulatory system. 2004 J. Cell. Biochem. pmid:15258896
Le Stunff H et al. Generation and metabolism of bioactive sphingosine-1-phosphate. 2004 J. Cell. Biochem. pmid:15258913
Duan HF et al. Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells. 2004 Exp. Cell Res. pmid:15265705
Melendez AJ and Ibrahim FB Antisense knockdown of sphingosine kinase 1 in human macrophages inhibits C5a receptor-dependent signal transduction, Ca2+ signals, enzyme release, cytokine production, and chemotaxis. 2004 J. Immunol. pmid:15265887
Deretic D et al. Phosphoinositides, ezrin/moesin, and rac1 regulate fusion of rhodopsin transport carriers in retinal photoreceptors. 2004 Mol. Biol. Cell pmid:13679519
Ikeda H et al. Sphingosine 1-phosphate enhances portal pressure in isolated perfused liver via S1P2 with Rho activation. 2004 Biochem. Biophys. Res. Commun. pmid:15240112